Viewing Study NCT05281718


Ignite Creation Date: 2025-12-25 @ 4:31 AM
Ignite Modification Date: 2025-12-26 @ 3:33 AM
Study NCT ID: NCT05281718
Status: COMPLETED
Last Update Posted: 2025-01-20
First Post: 2022-02-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Factor IX as Adjunctive Therapy to Emicizumab (EMIX)
Sponsor: Tulane University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module